ABSTRACT
INTRODUCTION
In China, an estimated 740,000 persons are infected with HIV, of whom approximately 105,000 have developed AIDS [1] . Of these, a cumulative of 319,877 patients, had been identified as of October 2009 [2] . Before 2002, when China initiated its National Free Antiretroviral Treatment Program as a pilot project among former plasma donors [3, 4] , antiretroviral therapy (ART) was not readily available. Treatment was rapidly scaled up, and by August 2008, more than 52,000 persons had received first-line highly active antiretroviral therapy (HAART). Traditional Chinese Medicine (TCM) intervention started from 2004, a pilot project named National Free TCM HIV/AIDS Treatment Program had been launched by The State Administrative bureau of Traditional Chinese Medicine, and quickly scaled up from 5 provinces (Henan, Hebei, Anhui, Hubei, Guangdong) to 19 provinces, autonomous regions, and municipalities in China including some places with high prevalence, 9267 cases have been treated with TCM accumulatively by 2009.
HIV weakens the immune system by attacking CD4 lymphocyte count, CD4 lymphocyte count is a strong predictor of assessing prognosis of AIDS. [5, 6] .
We report the 3-year outcome on CD4+ lymphocyte count of 807 cases of HIV/AIDS enrolled in the National Free TCM HIV/AIDS Treatment Program by retrospective analysis, the CD4+ lymphocyte count were measured every 6 month at 7 time points (0, 6, 12, 18, 24, 30, 36 month).
METHOD

Study Design and Setting
In China, all HIV-positive patients who meet the national treatment guidelines of CD4+ lymphocyte count less than 0.200 × 10 9 cells/L, total lymphocyte count less than 1.2 × 10 9 cells/L, or World Health Organization (WHO) stage 3 or 4 disease are eligible to receive HAART [7] .When National Free TCM HIV/AIDS Treatment Program launched by 2004, HIV-positive patients who were willing to receive TCM can be enrolled in TCM program, no matter its CD4+ lymphocyte count levels. After treatment initiation, visits are scheduled at 6 month, 12 months, 18 months, and then every 6 months thereafter. Local TCM health care providers from the program complete visit-specific forms at each visit, all the information was imputed into the database. We selected 807 cases from the database which had good TCM compliance. 80% of them were paid blood donors from Henan Province with average age at 41. Male 377, female 430, 222 cases of them had combined with HAART therapy. Chinese herb medicine adopted prescriptions according to syndrome differentiation or patent used by local doctors from each province.
Statistical Analysis
T-Test statistic was used in this study for quantitative variables. SPSS, version 13.0 (SPSS, Chicago, Illinois), and SAS, version 9.13 (SAS Institute, Cary, North Carolina), was used for all analyses. All hypothesis testing was 2-sided, with anαlevel of 0.05.
RESULTS
CD4+ Lymphocyte Count Overall Variation
The CD4+ lymphocyte count maintained stable at the 6th month and 12th month, declined significantly at the 18th month, 24th month and 30th month, then elevated to the pre-treatment level at 36th month ( Table 1) .
CD4+ Lymphocyte Count Variations by Different Pre-Treatment Level
Patients with pre-treatment CD4+ lymphocyte count level < 200/mm 3 , who possibly combined HAART therapy, had CD4+ lymphocyte count elevated significantly after all visits ( 
CD4+ Lymphocyte Count Variations by
Different Clinical Stages
CD4+ lymphocyte count of patients at both stage maintained stable at all visits which may implicated TCM effect (see Table 5 ,6). [8] . Experimental study also showed that Chinese herb compound prescription ZY-1 may help activation and hyperplasia of CD4 cell in lymph nodes [9] .
In our study, the overall CD4+ lymphocyte count maintained stable at the 6th month and 12th month, declined significantly at 18th month, 24th month and 30th month, then elevated to the pre-treatment level at 36th month, which was in accordance with the result of clinical trial conducted by Wang Jian et al. In that trial, CD4 count decreased in both groups (Aining granule + HAART; placebo + HAART) after 11 months treatment, the decrease of mean value of CD4 was significantly less in the Aining group (-87.65 ± 107.98/mm 3 ) than in the control group (-156.51 ± 157.04/mm 3 , P < 0.05) [10] . By analysis of database, Patients with pre-treatment CD4+ lymphocyte count level <200/mm 3 , who possibly combined HAART therapy, had CD4+ lymphocyte count elevated significantly after all visits. Patients with pre-treatment CD4+ lymphocyte count level between 200 and 350/mm 3 maintained stable before 36 months, and then rose significantly, which implicated the longterm effect of TCM. Patients with pre-treatment CD4+ lymphocyte count level > 350/mm 3 had CD4+ lymphocyte count declined significantly after all visits.
In summary, combined treatment of Chinese herbal medicine of HIV/AIDS suggested promising effect, but more evidence from larger, rigorous designed studies still needed to support the affirmative effect of TCM in the future.
